Dual specificity protein phosphatase 3 is an enzyme that in humans is encoded by the DUSP3gene.
The protein encoded by this gene is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. They negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), which are associated with cellular proliferation and differentiation. Different members of the family of dual specificity phosphatases show distinct substrate specificities for various MAP kinases, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. This gene maps in a region that contains the BRCA1 locus which confers susceptibility to breast and ovarian cancer. Although DUSP3 is expressed in both breast and ovarian tissues, mutation screening in breast cancer pedigrees and in sporadic tumors was negative, leading to the conclusion that this gene is not BRCA1.
^Folander K, Douglass J, Swanson R (Feb 1995). "Confirmation of the assignment of the gene encoding Kv1.3, a voltage-gated potassium channel (KCNA3) to the proximal short arm of human chromosome 1". Genomics23 (1): 295–6. doi:10.1006/geno.1994.1500. PMID7829094.
^ abTodd, J L; Tanner K G; Denu J M (May 1999). "Extracellular regulated kinases (ERK) 1 and ERK2 are authentic substrates for the dual-specificity protein-tyrosine phosphatase VHR. A novel role in down-regulating the ERK pathway". J. Biol. Chem. (UNITED STATES) 274 (19): 13271–80. doi:10.1074/jbc.274.19.13271. ISSN0021-9258. PMID10224087.
Kamb A, Futreal PA, Rosenthal J et al. (1995). "Localization of the VHR phosphatase gene and its analysis as a candidate for BRCA1". Genomics23 (1): 163–7. doi:10.1006/geno.1994.1473. PMID7829067.CS1 maint: Explicit use of et al. (link)
Jones KA, Black DM, Brown MA et al. (1995). "The detailed characterisation of a 400 kb cosmid walk in the BRCA1 region: identification and localisation of 10 genes including a dual-specificity phosphatase". Hum. Mol. Genet.3 (11): 1927–34. doi:10.1093/hmg/3.11.1927. PMID7874108.CS1 maint: Explicit use of et al. (link)
Todd JL, Tanner KG, Denu JM (1999). "Extracellular regulated kinases (ERK) 1 and ERK2 are authentic substrates for the dual-specificity protein-tyrosine phosphatase VHR. A novel role in down-regulating the ERK pathway". J. Biol. Chem.274 (19): 13271–80. doi:10.1074/jbc.274.19.13271. PMID10224087.
Alonso A, Saxena M, Williams S, Mustelin T (2001). "Inhibitory role for dual specificity phosphatase VHR in T cell antigen receptor and CD28-induced Erk and Jnk activation". J. Biol. Chem.276 (7): 4766–71. doi:10.1074/jbc.M006497200. PMID11085983.
Alonso A, Rahmouni S, Williams S et al. (2003). "Tyrosine phosphorylation of VHR phosphatase by ZAP-70". Nat. Immunol.4 (1): 44–8. doi:10.1038/ni856. PMID12447358.CS1 maint: Explicit use of et al. (link)
Kim HS, Song MC, Kwak IH et al. (2003). "Constitutive induction of p-Erk1/2 accompanied by reduced activities of protein phosphatases 1 and 2A and MKP3 due to reactive oxygen species during cellular senescence". J. Biol. Chem.278 (39): 37497–510. doi:10.1074/jbc.M211739200. PMID12840032.CS1 maint: Explicit use of et al. (link)
Ota T, Suzuki Y, Nishikawa T et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet.36 (1): 40–5. doi:10.1038/ng1285. PMID14702039.CS1 maint: Explicit use of et al. (link)
Rual JF, Venkatesan K, Hao T et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature437 (7062): 1173–8. doi:10.1038/nature04209. PMID16189514.CS1 maint: Explicit use of et al. (link)
Rahmouni S, Cerignoli F, Alonso A et al. (2006). "Loss of the VHR dual-specific phosphatase causes cell-cycle arrest and senescence". Nat. Cell Biol.8 (5): 524–31. doi:10.1038/ncb1398. PMID16604064.CS1 maint: Explicit use of et al. (link)
Hao L, ElShamy WM (2007). "BRCA1-IRIS activates cyclin D1 expression in breast cancer cells by downregulating the JNK phosphatase DUSP3/VHR". Int. J. Cancer121 (1): 39–46. doi:10.1002/ijc.22597. PMID17278098.